Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
American Journal of Epidemiology
|
February 6, 2010
Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data
Gayle S Bieler, G Gordon Brown, Rick L Williams, et al.
Pediatric Rheumatology Online Journal
|
January 23, 2009
Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
Robert J Brogan, Despina Eleftheriou, James Gnanapragasam, et al.
HIV Medicine
|
December 15, 2015
Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial
E Wilkins, M Fisher, A J Brogan, et al.
HIV Medicine
|
August 9, 2019
Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK
A J Brogan, S E Talbird, A E Davis, et al.
Brain Injury
|
April 26, 2017
Near-infrared spectroscopy (NIRS) to detect traumatic intracranial haematoma: A systematic review and meta-analysis
Robert J Brogan, Vassilios Kontojannis, Bhavin Garara, et al.
JAMA
|
October 26, 1999
Harassment of lesbians as medical students and physicians
D J Brogan, E Frank, L Elon, et al.
Human Vaccines & Immunotherapeutics
|
October 27, 2016
Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach
Anita J Brogan, Sandra E Talbird, Ashley E Davis, et al.
Pharmacoeconomics
|
June 8, 2014
Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada
Anita J Brogan, Erik Smets, Josephine A Mauskopf, et al.
Transplantation Proceedings
|
November 15, 2002
Effect of rapamycin and prednisolone in differentiated THP-1 and U937 cells
Y Y Liew, E Docter, D W Ray, et al.
Pharmacoeconomics
|
February 3, 2021
The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States
Anita J Brogan, Sandra E Talbird, Ashley E Davis, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
American Journal of Epidemiology
|
February 6, 2010
Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data
Gayle S Bieler, G Gordon Brown, Rick L Williams, et al.
Pediatric Rheumatology Online Journal
|
January 23, 2009
Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
Robert J Brogan, Despina Eleftheriou, James Gnanapragasam, et al.
HIV Medicine
|
December 15, 2015
Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial
E Wilkins, M Fisher, A J Brogan, et al.
HIV Medicine
|
August 9, 2019
Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK
A J Brogan, S E Talbird, A E Davis, et al.
Brain Injury
|
April 26, 2017
Near-infrared spectroscopy (NIRS) to detect traumatic intracranial haematoma: A systematic review and meta-analysis
Robert J Brogan, Vassilios Kontojannis, Bhavin Garara, et al.
JAMA
|
October 26, 1999
Harassment of lesbians as medical students and physicians
D J Brogan, E Frank, L Elon, et al.
Human Vaccines & Immunotherapeutics
|
October 27, 2016
Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach
Anita J Brogan, Sandra E Talbird, Ashley E Davis, et al.
Pharmacoeconomics
|
June 8, 2014
Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada
Anita J Brogan, Erik Smets, Josephine A Mauskopf, et al.
Transplantation Proceedings
|
November 15, 2002
Effect of rapamycin and prednisolone in differentiated THP-1 and U937 cells
Y Y Liew, E Docter, D W Ray, et al.
Pharmacoeconomics
|
February 3, 2021
The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States
Anita J Brogan, Sandra E Talbird, Ashley E Davis, et al.
Page
of 8